Fibrocell Science, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-16: Reporting owner Maslowski John Michael; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-11-09: Reporting owner Smith Kimberly M.; Form 3; Security Stock Options (right to buy); Transaction Holding.
- 2016-11-09: Reporting owner Smith Kimberly M.; Form 3; Security Stock Options (right to buy); Transaction Holding.
- 2016-11-09: Reporting owner Smith Kimberly M.; Form 3; Security Stock Options (right to buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-16 | Maslowski John Michael Director, Officer (CEO) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $0.66 exercise price | 2016-12-19 | |
| 2016-11-09 holding as of filing | Smith Kimberly M. Officer (Principal Accounting Officer) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $0.75 exercise price | 2016-11-09 | ||
| 2016-11-09 holding as of filing | Smith Kimberly M. Officer (Principal Accounting Officer) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $3.53 exercise price | 2016-11-09 | ||
| 2016-11-09 holding as of filing | Smith Kimberly M. Officer (Principal Accounting Officer) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $4.11 exercise price | 2016-11-09 | ||
| 2016-06-22 | Moore Kelvin Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.95 exercise price | 2016-06-24 | |
| 2016-06-22 | Smith Marcus E. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.95 exercise price | 2016-06-23 | |
| 2016-06-22 | Kirk Julian P. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.95 exercise price | 2016-06-23 | |
| 2016-06-22 | Swirsky Douglas J Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.95 exercise price | 2016-06-23 | |
| 2016-06-22 | Mazur Marc Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.95 exercise price | 2016-06-23 | |
| 2016-06-22 | St.Clare Christine Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.95 exercise price | 2016-06-23 | |
| 2016-03-01 | Maslowski John Michael Officer (SVP, Scientific Affairs) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $2.27 exercise price | 2016-03-02 | |
| 2016-03-01 | Goldan Keith A. Officer (SVP and CFO) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $2.27 exercise price | 2016-03-02 | |
| 2016-03-01 | Marino Michael F III Officer (SVP and General Counsel) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $2.27 exercise price | 2016-03-02 | |
| 2016-03-01 | Pernock David Director, Officer (Chairman and CEO) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +425,000 425,000 owned after | $2.27 exercise price | 2016-03-02 |